Drugs / PROSTVAC-VF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00078585 | Nov 2003 → Jan 2006 | prostate cancer | Bavarian Nordic | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PROSTVAC-VF | “PROSTVAC-VF comprises two recombinant viral vectors, each encoding transgenes for PSA, and three immune costimulatory molecules (B7.1, ICAM-1, and LFA-3).” PMID 20100959 ↗ Jan 2010 |
| Modality | Vaccine | “PROSTVAC-VF is an investigational cancer vaccine.” NCT00078585 ↗ |